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Abstract: Iodine sufficiency is particularly important in pregnancy, where median urinary iodine
concentration (UIC) in the range of 150–250 µg/L indicates adequate iodine status. The aims of
this study were to determine UIC and assess if dietary and maternal characteristics influence the
iodine status in pregnant Norwegian women. The study comprises a cross-sectional population-based
prospective cohort of pregnant women (Little in Norway (LiN)). Median UIC in 954 urine samples
was 85 µg/L and 78.4% of the samples (n = 748) were ≤150 µg/L. 23.2% (n = 221) of the samples
were ≤50 µg/L and 5.2% (n = 50) were above the requirements of iodine intake (>250 µg/L). Frequent
iodine-supplement users (n = 144) had significantly higher UIC (120 µg/L) than non-frequent users
(75 µg/L). Frequent milk and dairy product consumers (4–9 portions/day) had significantly higher
UIC (99 µg/L) than women consuming 0–1 portion/day (57 µg/L) or 2–3 portions/day (83 µg/L).
Women living in mid-Norway (n = 255) had lowest UIC (72 µg/L). In conclusion, this study shows
that the diet of the pregnant women did not necessarily secure a sufficient iodine intake. There is an
urgent need for public health strategies to secure adequate iodine nutrition among pregnant women
in Norway.
Keywords: urinary iodine concentration; iodine to creatinine ratio; supplement; milk and dairy
products; seafood; iodine status; pregnant
1. Introduction
A population’s dietary habits and its access to sources of iodine—such as seafood, milk and dairy
products, iodized salt, and iodine containing supplements—are important for securing sufficient iodine
intake. The frequency and quantity of consumption of these iodine sources are critical determinants
of the individual’s iodine status. Iodine is essential for thyroid hormone production, which plays a
crucial role in ensuring optimal growth and brain development of the fetus and child. Insufficient
iodine intake in utero and during early childhood may damage the developing brain, leading to the
loss of intellectual potential, making it one of the most important preventable causes of brain damage
worldwide [1]. Suboptimal iodine nutrition gives rise to concern since emerging evidence suggests
that children of women with an urinary iodine to creatinine ratio (UI/Cr) <150 µg/g in pregnancy
are more likely to have lower scores on verbal IQ, reading accuracy, and reading comprehension at
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eight years of age [2]. Results from the follow-up of the gestational iodine cohort (9-year and 15-year)
in Australia indicate that even mild iodine deficiency during pregnancy may have consequences for
the child that are not improved by sufficient iodine intake during childhood [3,4]. Adequate maternal
iodine status is therefore especially important since the fetus is dependent on maternal transfer of
thyroid hormones in early gestation and supply of iodine later in gestation. The recommended intake
of iodine during pregnancy is 175 µg/day in the Nordic countries [5] and 250 µg/day according to
World Health Organization (WHO) [6].
The urinary iodine concentration (UIC) captures the total iodine intake and is regarded as a
reliable biomarker for assessing recent iodine intake at a group level [7]. A median UIC in the range of
150–250 µg/L indicates adequate iodine nutrition in a population of pregnant women [8]. By using
a median cutoff of 150 µg/L, insufficient iodine status has been demonstrated in pregnant women
in several European countries during recent years [2,9–12]. The population in Norway has long
been considered iodine sufficient due to the contribution of iodine from milk and dairy products.
The Norwegian Mother and Child Cohort Study (MoBa), including more than 80 thousand pregnant
women, has challenged this assumption as a large proportion of these women was at risk of suboptimal
dietary iodine intake [13]. Studies assessing UIC from pregnant women in Norway confirm the findings
of insufficient dietary iodine intake [13–15]. Further, the MoBa study has shown that an estimated
dietary iodine intake <160 µg/day during pregnancy was associated with symptoms of child language
delay, behavior problems, and reduced fine motor skills at age three years [16].
Both season of the year and time point of urine sampling have been shown to influence the
UIC [17,18]. Studies also suggest that gestational week is of importance for the interpretation of
UIC in pregnancy [19,20]. With urine samples and dietary data from approximately one thousand
pregnant women, we aim to investigate their iodine status by measuring UIC and assess if maternal
characteristics and dietary factors may influence the iodine status. Further, we ask if gestational week,
time of urine sampling, season of the year, and creatinine levels may influence the interpretation of
iodine nutrition in pregnancy.
2. Materials and Methods
2.1. Study Population and Design
This study used samples and data collected as part of a population-based prospective cohort
designed to investigate pre- and postnatal risk factors influencing developmental malleability from
pregnancy to 18 months of age. Families were recruited from nine different public health clinics
across Norway. The clinics were chosen after considering demographic characteristics and size of
the population to include participants from both cities and rural districts with a wide distribution of
socioeconomic conditions. At each site, one midwife was trained as a research assistant and invited all
the pregnant women at 16–26 weeks gestation to participate, but some women were enrolled before
week 16 and some as late as week 30. Between September 2011 and mid-October 2012, 1041 families
were enrolled. Five families withdrew their consent, leaving us with 1036 mothers. Three families
were excluded due to stillbirth, and 26 were excluded for other reasons before birth of the child
(i.e., poor parental health, family moving out of the area, participation felt to be too time consuming).
These families let us keep the data we had already collected. We were left with 1007 mothers who
gave birth to 1017 children (including 10 twin pairs; multiple pregnancies other than twins have been
excluded). Figure 1 shows participation flowchart.
Data collection phases comprised five points in pregnancy, birth, and four follow-up points up
to age 18 months. Data collection up to 18 months was finished by November 2014. In this article
urine samples, dietary data, and demographic data from the pregnant women are used. The study was
conducted according to the guidelines in the Declaration of Helsinki and was approved by Regional
Committees for Medical and Health Research Ethics in Norway (REK 2011/560). Written informed
consent was obtained from all subjects.
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2.2. Data Collection and Categorization of Variables
A non-fasting urine sample was obtained from every pregnant woman in specimens collected at
each site. Gestational week, time of the day, and date of urine sample were registered. Since women
were enrolled in the study at different gestational weeks, the spot urine sample was categorized
into first (0–13 weeks of gestation), second (14–27 weeks of gestation), and third (28–40 weeks of
gestation) trimester. The time of day for sampling of the urine was categorized into morning (6–9 a.m.),
noon (10–13 a.m.), afternoon (14–17 p.m.), evening (18–24 p.m.), and night (0–5 p.m.). The date
of sampling was divided into four seasons; spring (March–May), summer (June–August), autumn
(September–November), and winter (December–February).
A comprehensive questionnaire package was given to mothers and fathers at the first meeting after
inclusion, which could take place from pregnancy week 16 to 34, depending on the specific time of
enrollment. All parents were asked to answer these questions, irrespective of exact time of inclusion.
Among the many questions, data on maternal (and family) characteristics such as age, weight before
pregnancy, height, parity, education, socio-economic status, and use of tobacco were obtained. Age of
participating women was divided in four categories; <25 years, 25–29 years, 30–34 years, and ≥35 years.
The residence of the women was divided into north, mid, west, and east regions of Norway. The north
area included women from one sampling site (Tromsø), mid from three samplings sites (Trondheim),
west (Bergen) from two sampling sites, and the east area of Norway included three different sampling
sites (Oslo). Parental education was categorized into primary and high school (low), University College
or University ≤4 years (middle), or University College or University ≥4 years (high). The income of the
mother was categorized as <300,000 NOK, 300,000–449,000 NOK, and ≥450,000 NOK.
Dietary data were collected using a web-based semi–quantitative food frequency questionnaire
(FFQ) covering the last three months intake of iodine rich foods, such as seafood, milk, dairy products,
and eggs in addition to some questions about the intake of other main food groups, such as fruit
and vegetables, bread and cereals, and meat and meat products [21,22]. The first question regarding
milk and dairy products asked if they consumed milk and dairy products daily or weekly (‘yes’ or
‘no’). A second question concerned portions of milk and dairy products intake per day, which was
categorized as 0–1 portions/day, 2–3 portions/day, and 4–9 portions/day. As to the first question,
the non-daily users were included in the category 0–1 portions/day. The seafood intake was recoded
to estimate the weekly intake for dinner and the daily intake of seafood as bread spread. Follow-up
questions regarding type of seafood were asked to differentiate between lean fish, fatty fish, and the
frequency of use of processed fish products (i.e., fish cakes, fish fingers, etc.). The weekly intake of
seafood for dinner was then dichotomized into <2 portions/week and ≥2 portions/week. Several
questions regarding the use of supplements were asked, answers were divided into non-iodine
containing supplement and iodine containing supplement based on information given in several
questions. Supplement use was then dichotomized as users (≥5 times/week) and non-users
(<5 times/week). The level of iodine in supplements on the Norwegian marked varies from 50
to 225 µg. The maximum level to be added is set to 225 µg iodine per daily dose.
2.3. Laboratory Analysis
The spot urine samples were stored at minus 20 ◦C approximately one month at each sampling
site before all samples were shipped to Institute of Marine Research (IMR) and stored at minus 20 ◦C
until analysis of iodine and creatinine concentrations was carried out. Prior to analysis, the urine
samples were defrosted in a refrigerator. For the determination of iodine, 500 µL urine was diluted in
4.5 mL 1% tetrametylammonium hydroxide (TMAH) and filtered using a sterile membrane filter with
a 0.45 µm pore size and a single use syringe. Samples were analyzed against a urine calibration curve
(standard addition curve) to measure the unknown iodine concentration (127I) in the collected urine
samples. The accuracy of the results was verified with certified reference material; Seronorm Trace
Elements Urine (Nycomed Pharma, Asker, Norway) with certified iodine content of 84 µg/L (range
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72–96 µg/L) and 304 µg/L (range 260–348 µg/L). UIC was determined by inductively coupled plasma
mass-spectrometry (ICP-MS).
For the urinary creatinine determination, the urine samples were defrosted at room temperature
and centrifuged in an Eppendorf (5810R) centrifuge (15 min, 2000× g and 4 ◦C). An aliquot of 200 µL
was transferred to the test tube and placed in the Maxmat carousel. All sample treatment was automatic;
samples were diluted 1:20 with distilled water and reagents added. Determination of creatinine was
performed by a colorimetric enzymatic principle using a MAXMAT PL II multidisciplinary diagnostic
platform using the Creatinine PAP kit, (ERBA Diagnostics, Montpellier, France). The method was
calibrated with one standard and further controlled with two independent controls.
Creatinine concentration was also used to determine whether the spot urinary sample was valid.
We have excluded urine samples with creatinine concentration outside the WHO guidelines of <0.3 g/L
and >3.0 g/L [23].
2.4. Statistics
We report iodine status in two ways; as the urinary iodine concentration (µg/L) and as the urinary
iodine per gram creatinine (µg/g). Both measures were used to explore relations with participants’
characteristics and dietary intake by using independent samples Mann–Whitney U Test. Medians and
25th and 75th percentiles are reported for all these variables (Table 1). The 24-h excretion of iodine
(UIE) was estimated by multiplying the iodine-to creatinine ratio by the expected daily excretion of
creatinine 1.23 [24]. Spearman’s correlations were calculated for UIC, maternal characteristics and
intake of iodine rich foods. Variables that showed a relation with the UIC and iodine to creatinine ratio
in the unadjusted analysis (Table 1) were entered in the linear regression model to evaluate associations
between maternal characteristics or dietary factors (Tables 2 and 3). The relationship between UIC
or IU/Cr ratio was explored by linear regression, and we used a standard multiple regression model.
Two-tailed p-values < 0.05 were considered statistically significant. The statistical software package
Statistical Package for the Social Sciences (SPSS® Statistics Version 24) was used for all data analyses.
Table 1. Urinary iodine concentration (µg/L (UIC)) and urinary iodine to creatinine ratio (µg iodine/g
creatinine (UI/Cr ratio)) according to maternal demographic and behavioral characteristics given as
median with 25th and 75th percentiles in the study population.
n UIC (µg/L) p-Value * UI/Cr Ratio (µg/g) p-Value *
Maternal age, years 937 0.429 0.100
<25 114 80 (53–143) 71 (46–124)
25–29 348 85 (50–130) 79 (49–122)
30–34 305 83 (54–120) 86 (59–121)
≥35 170 88 (51–160) 86 (54–139)
Smoking (daily) while pregnant 954 0.128 0.019
No 882 85 (57–140) 83 (54–125)
Yes 72 70 (44–120) 64 (45–107)
Parity 954 0.846 0.034
0 547 78 (44–130) 90 a (55–138)
1 337 82 (52–135) 80 a,b (52–119)
≥2 120 80 (43–130) 75 b (45–118)
Educational level 954 0.217 <0.0001
Primary 1/high school 231 78 (48–130) 73 a (45–121)
College/University < 4 year 360 85 (47–140) 82 a,b (53–123)
College/University ≥ 4 year 413 78 (47–130) 90 b (59–134)
Cohabitation 954 0.632 0.844
Living with partner 912 79 (47–130) 83 (53–127)
Not living with partner 42 85 (47–130) 83 (50–139)
Ethnicity 954 0.126 0.229
Norwegian 945 78 (47–130) 82 (53–127)
Other than Norwegian 59 92 (56–140) 90 (59–121)
Income (mother) 954 0.331 0.007
<300,000 NOK 320 78 (45–130) 82 a (50–124)
300,000–449,000 NOK 453 80 (47–130) 80 a (51–126)
≥450,000 NOK 231 79 (50–140) 94 b (60–138)
1 31 participants have completed primary school. Different letters indicate statistical differences. * p-value for
differences between groups using Mann-Whitney U to compare two groups or Kruskall–Wallis test comparing
categories with more than two groups.
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Table 2. Urinary iodine concentration (µg/L (UIC)) and urinary iodine to creatinine ratio (µg iodine/g
creatinine (UI/Cr ratio)) according to maternal sample collection characteristics given as median with
25th and 75th percentiles in the study population.
n UIC (µg/L) p-Value * UI/Cr Ratio (µg/g) p-Value *
Trimester 924 0.052 0.003
First (0–13 week) 10 66 (41–155) 87 a (44–105)
Second (14–27 week) 674 83 (50–130) 79 a (50–119)
Third (28–44 week) 240 92 (57–150) 94 b (60–145) 0.001
Residence in Norway 954 <0.0001 <0.0001
North 144 82 b (49–128) 83 a (52–113)
Mid 255 72 a (44–110) 66 a (47–107)
West 217 83 b (53–130) 75 a (48–112)
East 338 100 b (61–150) 98 b (64–147)
Time of urine sampling 949 0.283 <0.0001
Morning (06 a.m.–10 a.m.) 262 79 (50–120) 72 a (47–105)
Noon (10 a.m.–02 p.m.) 305 87 (54–140) 81 a,c (50–117)
Afternoon (02 p.m.–07 p.m.) 299 90 (54–140) 95 b (59–142)
Evening/night (07 p.m.–06 a.m.) 35 90 (40–150) 107 b (58–148)
Season of urine sampling 899 0.006 0.006
Winter (Dec.–Feb.) 264 91 a (51–140) 93 a (58–132)
Spring (Mar.–May.) 239 90 a (55–140) 86 a,b (53–126)
Summer (Jun.–Aug.) 132 85 a,b (50–130) 76 b (44–120)
Autumn (Sep.–Nov.) 264 73 b (46–120) 74 b (52–114)
Different letters indicate statistical differences. * p-value for differences between groups using Mann–Whitney U to
compare two groups or Kruskall–Wallis test comparing categories with more than two groups.
Table 3. Urinary iodine concentration (µg/L (UIC)) and urinary iodine to creatinine ratio (µg iodine/g
creatinine (UI/Cr ratio)) according to selected maternal dietary intake given as median with 25th and
75th percentiles in the study population.
n UIC (µg/L) p-Value * UI/Cr Ratio (µg/g) p-Value *
Dietary factors
Seafood dinner 934 0.539 0.103
<2 portions/week 653 78 (48–130) 82 (51–126)
≥2 portions/week 281 80 (47–125) 88 (57–129)
Egg 821 0.430 0.156
<3 eggs/week 701 80 (49–130) 82 (53–127)
≥3 eggs/week 120 78 (36–140) 92 (55–145)
Dairy products 806 <0.0001 <000.1
0–1 portion/day 153 57 a (39–110) 64 a (45–110)
2–3 portion/day 524 83 b (48–130) 83 b (55–130)
4–9 portions/day 128 99 b (59–168) 105 c (77–150)
Iodine supplement use 948 <0.0001 <0.0001
Yes (≥5 times/week) 144 120 a (72–208) 140 a (84–233)
No (<5 times/week) 804 75 b (44–120) 78 b (51–116)
Different letters indicate statistical differences. * p-value for differences between groups using Mann–Whitney U to
compare two groups or Kruskall–Wallis test comparing categories with more than two groups.
3. Results
A total of 954 pregnant women were included in this study, which corresponds to 92.1% of the
women consenting to participate (Figure 1). Median age at the time of enrollment was 30 years, with a
range of 17–43 years, median weight before pregnancy was 64 kg, with a range of 42–158 kg, and the
median height was 167 cm, with a range of 130–184 cm. Median gestational week for the collection of
urine sample was 25 (second trimester), with a range of 9–34 weeks.
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Figure 1. Flowchart of study participants in the current study.
3.1. Urinary Iodine Distribution
The median UIC and the UI/Cr was 85 µg/L and 82 µg/g, respectively. The overall UIC varied
from 5 to 770 µg/L and 78.4% of the pregnant women (n = 748) had an UIC less than 150 µg/L.
The overall UI/Cr varied from 11 to 1196 µg/g and 84.2% (n = 802) had IU/Cr below 150 µg/g.
The estimated daily urinary iodine excretion (UIE) was 101 µg/day, with a range of 14 to 1471 µg/day.
The distribution of UIC and UI/Cr in the total study population is shown in Figure 2.
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3.2. Urinary Iodine Distribution in Relation to Maternal Characteristics
Tables 1–3 presents the UIC (µg/L) and UI/Cr (µg iodine/g creatinine) with 25th and 75th
percentiles according to maternal demographic, behavioral, and dietary intake characteristics.
Maternal residence, season of urine sampling, intake of dairy products and use of supplements
differed significantly in the study group (Tables 2 and 3). These variables were all significantly
associated with both UIC and UI/Cr in a non-parametric test.
Pregnant women living in mid-Norway had significantly lower UIC than women living in
north, west or east-Norway. The UI/Cr was significantly higher in women living in east-Norway
compared with the three other areas (north, mid, and west). Samples collected during autumn
(September–November) yielded significantly lower UIC compared with winter (December–February)
and spring (March–May) samples. The UI/Cr values showed a different pattern, as the winter samples
were significantly higher than summer and autumn samples. Trimester, time (hour) at urine sampling,
smoking, parity, education, and income were all significantly associated with UI/Cr (p < 0.01) but
not with the UIC. Most of the samples were collected in the second trimester; however, IU/Cr was
significantly higher in third trimester compared to first and second trimester. UI/Cr was significantly
lower in morning and noon samples compared to afternoon and evening/night samples. Furthermore,
UI/Cr was significantly lower in mothers with two or more children compared with non-parous and
mothers with one child. Mothers with highest education (≥4 years college/university education) and
mothers with highest income (≥450,000 NOK) had higher UI/Cr compared to mothers with lower
education and income, respectively.
The intake of milk and dairy products was more important for the iodine status than the seafood
intake as 95.4% of the mothers consumed dairy product daily. The majority (65.2%) of the women
reported eating 2–3 dairy portions per day, 14.3% reported an intake of 1 portion per day, and 14.9%
reported an intake of 4–6 portions of milk and dairy products per day. Only 1.1% ate 7–9 portions
of dairy products per day. The questionnaire did not distinguish between milk, cheese and yoghurt
intake, only between portions of intake per day. Of the 4.6% (n = 38) non-daily users of milk and
dairy products, we were not able to distinguish between non-users and weekly users of milk and
dairy products. However, when asked about foods they avoided, eight of the participants reported no
consumption of milk and dairy products. Both the UIC and UI/Cr were significantly higher in women
consuming ≥2 portions of dairy products as compared with women consuming 0–1 portion/day
(Table 1).
The frequency of seafood intake for dinner (n = 823) was 1–3 times per month or less among 27.8%,
once per week among 42.1%, 2–3 times per week for 28.3% and ≥4 times per week among 1.6% of the
women during pregnancy. Consumption of seafood as spread (n = 823) showed that 59.2% consumed
it seldom, 30.4% 1–2 times/week, and 10.4% consumed seafood as spread ≥3/week. As regards egg
intake, 46.9% reported consuming ≤1 egg per week, 11.9% reported consuming 2–3 eggs per week,
and 2.7% ate ≥4 eggs per week.
Use of any type of supplement was reported by 48% at enrollment, however only 15.1% of the
women were categorized as users of iodine supplement (i.e., ≥5 times/week). The most frequent
used supplement was omega-3 capsules. Both UIC and UI/Cr were significantly higher among
iodine-containing supplement users compared to non-users (Table 3).
3.3. Assignments between UIC and UI/Cr Ratio
The correlation between UIC (µg/L) and UI/Cr (µg/g) was high and significant (Spearmans rho
0.65). Figure 3 illustrates that the participants were assigned in the same or in the adjacent tertile,
and that only one participant was grossly misclassified (i.e., UIC <50 µg/L and UI/Cr of >150 µg/L).
The agreement of tertiles assignment between UIC and UI/Cr was 63.4% in the samples when the
UIC was divided into <50 µg/L, ≥50–150 µg/L, and >150 µg/L (Figure 3). Of the 221 participants
with UIC <50 µg/L, 107 (48.4%) had UI/Cr ≥50 µg/g (Figure 3). Oppositely, 212 participants had
UI/Cr <50 µg/g and 93 participants had UIC ≤50 µg/L. In summary, 111 participants had both UIC
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and UI/Cr <50 µg/L. The agreement of dichotomization of assignment between UIC and UI/Cr
ratio showed that 83.9% were correctly assigned into the same category when UIC was divided into
≤150 µg/L and >150 µg/L (Figure 3).
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3.4. Association between Iodine Status and Maternal Characteristics
In linear regression analyses using UIC as the dependent variable, three variables were
significantly related to UIC; use of iodine supplement, intake of dairy products, and maternal residence.
(Table 4). The same linear regression model using UI/Cr as the dependent variable showed a positive
significant linear relationship between UI/Cr and use of iodine supplement, intake of dairy products,
trimester, and time (hour) of urine sampling (Table 5). Additional adjustments of other factors were
not significant and were excluded from the model (p > 0.05). The associations with use of iodine
supplement and intake of dairy products were related to the level of iodine in both regression models.
l 4. i i c i re it I ( g/
t i l .
Variable B SEB β
Intercept 43.963 12.961
Supplement user 61.839 7.601 0.287 *
Dairy product intake 16.124 4. 09 0.116 *
Residence 7.230 2.715 0.94 *
* p < 0.05; B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β = standardized coefficient.
Nutrients 2018, 10, 513 9 of 14
Table 5. Predictors of urinary iodine to creatinine ratio (UI/Cr) in pregnant women with UI/Cr
(µg iodine/g creatinine) as dependent variable.
Variable B SEB β
Intercept −28.988 19.443
Supplement user 87.751 7.955 0.381 *
Dairy product intake 19.38 5.149 0.131 *
Time of urine sampling 15.633 3.461 0.157 *
Trimester 21.283 6.82 0.108 *
* p < 0.05; B = unstandardized regression coefficient; SEB = Standard error of the coefficient; β = standardized coefficient.
4. Discussion
The main finding of this study was that median UIC was 85 µg/L, which is below the
recommended cut off value of 150 µg/L set by WHO [8]. This suggests that many of the pregnant
women in this study had an insufficient iodine intake. In fact, almost 80% of the women had a UIC
<150 µg/L. Dietary factors such as use of iodine supplements and intake of dairy products, as well
as residence of the mother and season of urine sampling, were all significantly associated with both
UIC and UI/Cr. The agreement of correct assignments between UIC and UI/Cr was 84% when the
UIC was dichotomized (<150 µg/L and >150 µg/L); 111 women (11.5%) had both UIC and UI/Cr
<50 µg/L. To our best knowledge, this is the first survey using UIC and UI/Cr in such a large sample
of pregnant women living in several areas in Norway.
Insufficient iodine nutrition in pregnant women has been demonstrated in several European
countries. In studies from Austria [11], Belgium [25], Denmark [9], Latvia [26], Poland [12],
Portugal [27], Spain [28], Sweden [10], and the UK [19], the median UIC was in the range from
57 µg/L in UK to 140 µg/L in Spain. In contrast, only a few studies have reported sufficient iodine
intake in pregnant women. In Iceland, the median UIC was 200 µg/L [29] and in the Netherlands
UIC was 230 µg/L in pregnant women [30]. In studies from Norway, median UIC was 92 µg/L
(n = 777) in pregnant women living in the Oslo area from 2016 [15], 84 µg/L (n = 197) in the Northern
Mother-and-Child contaminant cohort (MISA) from 2007–2009 [14], and 69 µg/L in the MoBa cohort
(n = 119) from 2003–2004 [13]. In the MISA study and in the MoBa cohort, 80% and 89%, respectively,
of the pregnant women had UIC <150 µg/L. The UIC levels in the Oslo area, MISA, MoBa, and our
study are in line with results from the estimated dietary iodine intake in more than 60 thousand
mothers in the MoBa cohort study [13]. In the MoBa study, 54.3% had an estimated iodine intake
below the Nordic recommendation of 175 µg/day and only 21.7% of the women reached the WHO
recommendation of 250 µg iodine/day. In the Oslo area study, 55% had a calculated iodine intake
below estimated average requirement (EAR) of 160 µg/day [15]. Our study, as was also the case for the
estimated iodine intake in the MoBa study [13] and the study in the Oslo area [15], comprised many
participants and therefore suggest that pregnant women in Norway are at risk of having insufficient
iodine intake.
Even though several factors determine the level of iodine in urine, the UIC captures the total
iodine intake from all dietary sources [7]. In our study, we found a strong relationship between UIC
or UI/Cr and iodine supplement intakes and the intake of milk and dairy products. In studies from
Denmark [9], Poland [12], and the UK [19] it was also reported a higher UIC or UI/Cr in pregnant
women using iodine supplements and/or consumed ≥2 portions of milk and dairy products per day.
The MoBa study has also shown that the estimated dietary iodine intake was strongly associated with
the intake of iodine supplement, milk and dairy products, and seafood [13]. Since fortification of
cow fodder started around 1950 in Norway, milk and dairy products have, been the most important
dietary iodine source for Norwegians [31]. This was confirmed in a study using dietary data from
a representative sample of Norwegians [32], and by the MoBa study using dietary data of pregnant
women [13]. However, the total iodine intake is still not in accordance with the recommendation.
Analysis of the iodine content in milk and dairy products in Norway in 2000 [33] showed a seasonal
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variation, but more recent analyses show that this variation has been less pronounced in recent
years [34,35]. The urine samples in the present study were collected in 2011–12. Although we found
a seasonal effect of UIC, meaning that UIC in samples collected in the winter (December–February)
was significantly higher than in autumn (September–November), this difference was not related to a
higher intake of milk and dairy products or supplement intake among these women. Therefore, it is
reasonable to speculate that the iodine level in the milk and dairy products was higher during the
winter season at the time of the data collection in the present study (i.e., 2011–12). As to residence, the
women living in the eastern part of Norway with significantly higher UIC, did not have a higher milk
and dairy or supplement intake than women living in the three other parts of Norway (mid, north,
or west). Even if we found these higher UIC related to season and residence, all UIC levels were below
the cut off value of ≤150 µg/L.
Although, seafood intake contributes to the iodine intake, the study among pregnant women in
Iceland is the only one showing that fish intake of ≥2 times/week results in UIC above 150 µg/L [29].
The intake of haddock (lean fish) was reported by 83% of Icelandic women. The iodine content
within and between fish species varies, and in general, lean fish has higher levels of iodine than fatty
fish [32,35]. The lack of associations between UIC or UI/Cr and intake of seafood in the present study
is most likely due to the fact that approximately 30% of the women reported to consume seafood in
accordance to the recommendation of 300–450 g/week. However, since the urine reflects only the last
day of iodine intake, it would be more difficult to find a correlation with seafood intake which is eaten
2–3 times per week than milk and dairy products which are consumed more on a daily basis.
UIC is not recommended to be applied at an individual level. By using UIC and UI/Cr,
respectively, for the classification of iodine deficiency, one may inadvertently come to classify women
into different groups. By using UIC, our results showed that 221 (23.2%) of the women were classified
with an UIC below 50 µg/L. By using the UI/Cr, 212 (22.2%) were so classified. Although the number
of women is quite similar by both methods, only 111 individuals were assigned to the same group,
i.e., had both UIC and UI/Cr <50 µg/L. This is a caveat to the effect that one should be careful when
selecting the classification criterion. The inter- and intra-individual variation in UIC is caused by
variation in fluid intake as well as differences in iodine intake. Since the creatinine excretion is relatively
constant, the use of creatinine adjustments can minimize the variation in UIC caused by variation
in the urine volume [36]. In the study by Henjum et al. 2018 [15] a sub-study group of 49 pregnant
women had a median urine volume of 1.4 L. Considering this, we have overestimated the proportion
of pregnant women having an UIC <150 µg/L when using the WHO criteria [8].
The relationship of UIC or UI/Cr to maternal characteristics shows conflicting results. We found
that trimester, time of the day of urine sampling, smoking, parity, education, and income were
significantly associated with the UI/Cr (p < 0.01) but not with the UIC. Studies using UIC have reported
a reduction of UIC throughout pregnancy [17,20,37,38] or an increase of UIC [19,28]. UIC in our study
increased with trimester, however not significantly. Studies using UI/Cr also report increasing level of
UI/Cr by increasing gestational week [19,25,26] and others have reported decreasing level of UI/Cr
throughout pregnancy [39].
This study has several strengths. Since the women were recruited year-round, the seasonal bias
noted in other studies was reduced. The women were recruited from several regions in Norway and
this is the first study using spot urine samples in a large sample of pregnant women. UIC is the
recommended marker of assessments of iodine nutrition in population studies by WHO, and with
almost 1000 samples we were able to estimate the iodine level within a precision range of ±5% [36].
Further, analysis of iodine was performed with ICP-MS, which is a highly accurate method. The high
retention rate is a strength to this study. This was possibly due to the participants being followed
up by health care nurses serving as research assistants. One limitation is that most of the samples
were collected in the second, and not in first trimester. It should be noted that the project is not a
study of a truly representative population in terms of socioeconomic background. However, the study
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population is sufficiently large to conclude that the median UIC or UI/Cr indicate insufficient iodine
intake in the population [40].
Insufficient iodine intake among pregnant women is widespread in Europe. The lack of knowledge
about the importance of iodine and about dietary sources of iodine among women can be regarded as
a risk factor for iodine deficiency [41]. More attention by health care providers, including obstetricians
and midwives, may be important in solving this problem, along with the identification of new strategies
capable to increase the knowledge of and awareness in the general population [42]. Today, there is no
national monitoring of iodine status of the Norwegian population, but according to a national plan
of action for a better diet, public authorities should follow-up initiatives to improve and secure the
iodine intake [43]. Iodized salt is the most important source worldwide and is the agreed strategy for
achieving iodine sufficiency [8]. In Norway, iodized salt is available as table salt, however the level
of iodine is only 5 µg/g, and the food industry is not permitted to use iodized salt. To improve the
situation in Norway, the health authorities have recently initiated a risk–benefit analysis of increased
iodization of table salt and iodization of bread products. Another action is to recommend iodine
supplementation to pregnant women and other vulnerable groups with low consumption of milk.
5. Conclusions
These findings may potentially be of great public health importance, suggesting that a large
proportion of pregnant women in Norway is iodine deficient. Further studies should investigate to
what extent inadequate iodine status during pregnancy influences developmental skills in infancy,
as well as the thyroid function of the mothers. In conclusion, this study adds to the increasing evidence
that pregnant women in Norway are iodine deficient and that the diet of pregnant women does not
secure a sufficient iodine intake. There is an urgent need for public health strategies to secure adequate
iodine nutrition among pregnant women in Norway.
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